Suketu Upadhyay Zimmer Biomet Holdings, Inc. (ZBH) insider trading activity

Suketu Upadhyay is Exec. VP, CFO of ZIMMER BIOMET HOLDINGS, INC.. Currently has a direct ownership of 48,853 shares of ZBH, which is worth approximately $5.37 Million. The most recent transaction as insider was on Mar 06, 2025, when has been sold 2,029 shares (Common Stock) at a price of $104.86 per share, resulting in proceeds of $212,760. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.9K

64.24% 3M change

135.28% 12M change

Total Value Held $5.37 Million

Suketu Upadhyay Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2025	SELL Payment of exercise price or tax liability	$212,760 $104.86 p/Share	2,029 Reduced 3.99%	48,853 Common Stock
Mar 06 2025	BUY Exercise of conversion of derivative security	-	4,560 Added 8.22%	50,882 Common Stock
Feb 20 2025	SELL Payment of exercise price or tax liability	$250,683 $103.46 p/Share	2,423 Reduced 4.97%	46,322 Common Stock
Feb 20 2025	BUY Exercise of conversion of derivative security	-	5,446 Added 10.05%	48,745 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$823,655 $101.0 p/Share	8,155 Reduced 15.85%	43,299 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	-	21,622 Added 29.59%	51,454 Common Stock
Nov 10 2024	SELL Payment of exercise price or tax liability	$769,882 $108.48 p/Share	7,097 Reduced 19.26%	29,745 Common Stock
Nov 10 2024	BUY Exercise of conversion of derivative security	-	15,948 Added 30.21%	36,842 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$241,448 $125.82 p/Share	1,919 Reduced 8.46%	20,764 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	-	4,561 Added 16.74%	22,683 Common Stock
Feb 25 2024	SELL Payment of exercise price or tax liability	$269,320 $128.8 p/Share	2,091 Reduced 10.34%	18,122 Common Stock
Feb 25 2024	BUY Exercise of conversion of derivative security	-	7,043 Added 25.84%	20,213 Common Stock
Jul 01 2023	SELL Payment of exercise price or tax liability	$245,697 $146.51 p/Share	1,677 Reduced 11.44%	12,983 Common Stock
Jul 01 2023	BUY Exercise of conversion of derivative security	-	3,768 Added 20.45%	14,660 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$144,063 $124.73 p/Share	1,155 Reduced 9.59%	10,892 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	3,860 Added 24.27%	12,047 Common Stock
Jul 01 2022	SELL Payment of exercise price or tax liability	$132,207 $105.85 p/Share	1,249 Reduced 13.53%	7,982 Common Stock
Jul 01 2022	BUY Exercise of conversion of derivative security	-	3,768 Added 28.99%	9,231 Common Stock
Jul 01 2021	SELL Payment of exercise price or tax liability	$180,077 $161.94 p/Share	1,112 Reduced 17.33%	5,304 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	-	3,655 Added 36.29%	6,416 Common Stock

Also insider at

VRTX

VERTEX PHARMACEUTICALS INC Healthcare

Director

Suketu Upadhyay

Exec. VP, CFO

Warsaw, IN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZBH shares.

Notify only if

Value

Insider Trading

Get notified when an Zimmer Biomet Holdings, Inc. insider buys or sells ZBH shares.

Notify only if

Operation

Value

Type

News

Receive news related to ZIMMER BIOMET HOLDINGS, INC.

Track Activities on ZBH

Account